# Multiple Dose-parallel-group Study of AMA0076 in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension

> **NCT02136940** · PHASE2 · COMPLETED · sponsor: **Amakem, NV** · enrollment: 103 (actual)

## Conditions studied

- Glaucoma
- Ocular Hypertension
- Eye Disease

## Interventions

- **DRUG:** AMA0076
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02136940
- **Lead sponsor:** Amakem, NV
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-04
- **Primary completion:** 2014-11
- **Final completion:** 2014-12
- **Target enrollment:** 103 (ACTUAL)
- **Last updated:** 2015-01-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02136940

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02136940, "Multiple Dose-parallel-group Study of AMA0076 in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02136940. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*